BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -369.94 Million SEK | -657.61% |
| 2022 | -4.82 Million USD | 84.25% |
| 2021 | -30.65 Million USD | -230.33% |
| 2020 | -9.27 Million USD | 36.57% |
| 2019 | -14.62 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -10.53 Million USD | 27.83% |
| 2024 Q1 | -8.38 Million SEK | 19.45% |
| 2024 Q2 | -148.32 Million SEK | -65.43% |
| 2023 Q1 | -7.73 Million USD | -1.76% |
| 2023 Q4 | -10.99 Million USD | -48.49% |
| 2023 FY | -36.57 Million USD | -657.61% |
| 2023 Q3 | -7.4 Million USD | 17.56% |
| 2023 Q2 | -8.98 Million USD | -16.17% |
| 2022 Q2 | 16.32 Million USD | 0.0% |
| 2022 FY | -4.82 Million USD | 84.25% |
| 2022 Q4 | -7.59 Million USD | -20.7% |
| 2022 Q3 | -6.29 Million USD | -138.57% |
| 2021 FY | -30.65 Million USD | -230.33% |
| 2020 FY | -9.27 Million USD | 36.57% |
| 2019 FY | -14.62 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -415.34% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 7627.085% |
| SQZ Biotechnologies Company | -75.82 Million USD | -387.889% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -1972.853% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 551.965% |
| Mesoblast Limited | -84.14 Million USD | -339.638% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -23983.997% |
| Genus plc | 6.4 Million USD | 5880.344% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 3897.214% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -39619.771% |
| Marizyme, Inc. | -34.08 Million USD | -985.303% |
| ContraFect Corporation | -56.88 Million USD | -550.287% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -4330.443% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -8022.157% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -26286.903% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -12878.112% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -13348.333% |
| MultiCell Technologies, Inc. | -722.81 USD | -51180984.932% |
| Accustem Sciences Inc. | -3.74 Million USD | -9774.55% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -527.127% |
| EV Biologics, Inc. | -483.06 Thousand USD | -76482.716% |
| Q BioMed Inc. | -3.44 Million USD | -10636.6% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 10550.339% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -94861.624% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -13979.502% |
| Biomind Labs Inc. | -1 Million USD | -36542.324% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -7481.487% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -5464.699% |
| Skye Bioscience, Inc. | -13.67 Million USD | -2605.876% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -18523.001% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -1235016.186% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -7233.596% |
| IMV Inc. | -38.67 Million USD | -856.627% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -2231.116% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -19042.093% |
| GB Sciences, Inc. | -1.42 Million USD | -25942.918% |
| Alpha Cognition Inc. | -9.7 Million USD | -3711.634% |
| HST Global, Inc. | -140.9 Thousand USD | -262443.38% |
| CSL Limited | 3.7 Billion USD | 109.993% |
| Halberd Corporation | -75.05 Thousand USD | -492827.382% |
| Enzolytics Inc. | -2.14 Million USD | -17116.214% |
| Resverlogix Corp. | -12.74 Million USD | -2801.733% |
| Affymax, Inc. | -15.04 Million USD | -2358.74% |
| SYBLEU INC | -149.18 Thousand USD | -247883.644% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -11576.452% |
| argenx SE | -425.04 Million USD | 12.965% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -566.466% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -35335.057% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -23323.613% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -10764.737% |
| AVAX Technologies, Inc. | 6.69 Million USD | 5627.396% |
| Zenith Capital Corp. | -8.94 Million USD | -4036.666% |
| Genscript Biotech Corporation | -415.79 Million USD | 11.027% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -2123440.555% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -14966.975% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -215597.622% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -572.96% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -12651.125% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -37493.707% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -19742.735% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -29353.981% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -18353.209% |
| BioStem Technologies, Inc. | -7.77 Million USD | -4655.669% |
| ONE Bio Corp. | 13.68 Million USD | 2803.948% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -203741.64% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -27602.068% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -32786.481% |
| Agentix Corp. | -1.37 Million USD | -26868.499% |
| LadRx Corporation | -3.82 Million USD | -9575.162% |
| Cell Source, Inc. | -4.32 Million USD | -8452.888% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -88939.879% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -53752.828% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -53752.828% |
| NovAccess Global Inc. | -2.46 Million USD | -14897.081% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -12571.659% |
| Itoco Inc. | -919.14 Thousand USD | -40148.711% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -8628.312% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -32960.054% |
| Kadimastem Ltd | -3.04 Million USD | -12068.144% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -141247.058% |
| CytoDyn Inc. | -18.05 Million USD | -1948.632% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -1469673.54% |
| Mobile Lads Corp. | -554.55 Thousand USD | -66610.306% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -167995.857% |
| Qrons Inc. | -643.67 Thousand USD | -57373.236% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -65408.577% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -16490.228% |
| Rebus Holdings, Inc. | -664 Thousand USD | -55614.157% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -20267.666% |
| International Stem Cell Corporation | -663 Thousand USD | -55698.19% |
| Bioxytran, Inc. | -3.82 Million USD | -9583.973% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -702677.356% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -1818690.56% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -920.079% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -22764.153% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -50175.13% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -11791.418% |
| Neutra Corp. | -229.48 Thousand USD | -161104.605% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2009.254% |
| PureTech Health plc | -146.19 Million USD | -153.04% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -1621.371% |
| IXICO plc | -1.43 Million USD | -25644.05% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -3797.819% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -203.714% |
| CSL Limited | 3.81 Billion USD | 109.705% |
| Cellectis S.A. | -108.85 Million USD | -239.841% |